BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


SEARCH JOBS








 Company News
New Data From Upsher-Smith Laboratories's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy of Neurology 4/21/2014 10:36:19 AM    More...
Upsher-Smith Laboratories Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules 3/13/2014 6:26:32 AM    More...
Upsher-Smith Laboratories Honors 42 Pharmacists Nationwide For Excellence In Innovation 1/13/2014 12:11:25 PM    More...
Upsher-Smith Laboratories Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact 12/10/2013 11:34:08 AM    More...
Upsher-Smith Laboratories Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (Extended-Release Topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 12/9/2013 11:12:32 AM    More...
Auxilium Pharmaceuticals (AUXL) Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment 12/5/2013 11:36:07 AM    More...
Upsher-Smith Laboratories to Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Epilepsy In Patients With Refractory Partial-Onset Seizures at 2013 American Epilepsy Society Meeting 11/5/2013 9:31:48 AM    More...
Upsher-Smith Laboratories Reports Favorable Results From Phase 1 Clinical Trial of USL255 (Extended-Release Topiramate) at American Neurological Association's 2013 Annual Meeting 10/15/2013 10:36:26 AM    More...
Upsher-Smith Laboratories Announces Development Agreement With Lundbeck Inc. (LUN.CO) 10/1/2013 8:34:33 AM    More...
Upsher-Smith Laboratories Release: National Cholesterol Education Month Advice: Brush Up on Your Knowledge about Cholesterol and Heart Health, Says Leading Cardiologist 9/5/2013 8:49:43 AM    More...
12345678910...

//-->